https://scholars.lib.ntu.edu.tw/handle/123456789/478410
標題: | Safety and efficacy of Tien-Hsien Liquid Practical in patients with refractory metastatic breast cancer: A randomized, double-blind, placebo-controlled, parallel-group, phase IIa trial | 作者: | WEN-HUNG KUO CHIEN-AN YAO Lin C.H. KING-JEN CHANG |
公開日期: | 2012 | 卷: | 2012 | 起(迄)頁: | 803239 | 來源出版物: | Evidence-based Complementary and Alternative Medicine | 摘要: | To evaluate the safety and efficacy of Tien-Hsien Liquid Practical (THL-P), a Chinese herbal mixture, in patients with refractory metastatic breast cancer, we performed a randomized, double-blind, placebo-controlled, parallel-group, phase IIa pilot trial. Patients were randomly assigned to either receive THL-P or matching placebo and followed up every 4 weeks for 24 weeks. The primary endpoint was changes in the global health status/quality of life (GHS/QOL) scale. The secondary endpoints were changes in functional and symptom scales, immunomodulating effects, and adverse events. Sixty-three patients were enrolled between June 2009 and June 2011. The intent-to-treat population included 28 patients in the THL-P group and 11 patients in the placebo group. Compared to the placebo group, the THL-P group had significant improvement from baseline to last visit in GHS/QOL (41.7 versus 33.3; P < 0.05), CD3, CD4/CD8, CD19, CD16+56 positive cells (P < 0.05), and higher levels of physical, role, emotional, and cognitive functioning, as well as decreased fatigue and systemic side effects. Treatment-related adverse events were mild constipation and localized itching, and no serious adverse events were reported. THL-P appears to be a safe alternative adjuvant treatment for patients with refractory metastatic breast cancer, as it effectively improves QOL and palliates cancer-related symptoms. Copyright ? 2012 Wen-Hung Kuo et al. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861059890&doi=10.1155%2f2012%2f803239&partnerID=40&md5=487c32c0164c68470cf12b8e46a90dfe https://scholars.lib.ntu.edu.tw/handle/123456789/478410 |
ISSN: | 1741-427X | DOI: | 10.1155/2012/803239 | SDG/關鍵字: | CD16 antigen; CD19 antigen; CD3 antigen; CD4 antigen; CD8 antigen; herbaceous agent; tien hsien liquid practical; unclassified drug; adult; aged; article; breast metastasis; Chinese medicine; cognition; constipation; controlled study; double blind procedure; drug efficacy; drug safety; emotion; fatigue; female; follow up; health status; human; immunomodulation; intention to treat analysis; major clinical study; phase 2 clinical trial; physical activity; priority journal; pruritus; quality of life; refractory metastatic breast cancer |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。